Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference
Nuvation Bio (NYSE: NUVB), a late clinical-stage biopharmaceutical company focused on oncology, announced its upcoming participation in the 7th Annual Evercore ISI HealthCONx Conference. David Hung, M.D., the company's Founder, President, and CEO, will engage in a fireside chat at the conference in Coral Gables, Florida, on December 4, 2024, at 9:10 a.m. ET. The presentation will be accessible via live webcast on the company's investor website, with a recording available for 90 days afterward.
Nuvation Bio (NYSE: NUVB), una società biofarmaceutica in fase clinica avanzata focalizzata sull'oncologia, ha annunciato la sua prossima partecipazione alla 7ª Conferenza Annuale Evercore ISI HealthCONx. David Hung, M.D., fondatore, presidente e CEO dell'azienda, parteciperà a una chiacchierata informale durante la conferenza a Coral Gables, Florida, il 4 dicembre 2024, alle 9:10 a.m. ET. La presentazione sarà disponibile in diretta streaming sul sito web per investitori dell'azienda, con una registrazione disponibile per 90 giorni successivi.
Nuvation Bio (NYSE: NUVB), una empresa biofarmacéutica en etapa clínica avanzada centrada en oncología, anunció su próxima participación en la 7ª Conferencia Anual Evercore ISI HealthCONx. David Hung, M.D., fundador, presidente y CEO de la compañía, participará en una charla informal en la conferencia en Coral Gables, Florida, el 4 de diciembre de 2024, a las 9:10 a.m. ET. La presentación se podrá acceder a través de una transmisión web en vivo en el sitio web para inversores de la empresa, con una grabación disponible durante 90 días después.
Nuvation Bio (NYSE: NUVB), 종양학에 중점을 둔 후기 임상 단계의 생명공학 회사가 제7회 Evercore ISI HealthCONx 컨퍼런스에 참가한다고 발표했습니다. David Hung, M.D., 회사의 창립자이자 사장 및 CEO는 플로리다주 코랄 게이블스에서 2024년 12월 4일 오전 9시 10분 ET에 있는 컨퍼런스에서 대화에 참여할 예정입니다. 발표는 회사의 투자자 웹사이트를 통해 실시간 웹캐스트로 제공되며, 이후 90일 동안 녹화본도 제공됩니다.
Nuvation Bio (NYSE: NUVB), une entreprise biopharmaceutique en phase clinique avancée axée sur l'oncologie, a annoncé sa prochaine participation à la 7e Conférence Annuelle Evercore ISI HealthCONx. David Hung, M.D., le fondateur, président et PDG de l'entreprise, participera à un entretien lors de la conférence à Coral Gables, en Floride, le 4 décembre 2024, à 9h10 ET. La présentation sera accessible via un webinaire en direct sur le site web des investisseurs de l'entreprise, avec un enregistrement disponible pendant 90 jours par la suite.
Nuvation Bio (NYSE: NUVB), ein biopharmazeutisches Unternehmen in der späten klinischen Phase, das sich auf Onkologie konzentriert, hat seine bevorstehende Teilnahme an der 7. jährlichen Evercore ISI HealthCONx-Konferenz bekannt gegeben. David Hung, M.D., der Gründer, Präsident und CEO des Unternehmens, wird am 4. Dezember 2024 um 9:10 Uhr ET an einem Gespräch bei der Konferenz in Coral Gables, Florida, teilnehmen. Die Präsentation wird über einen Live-Webcast auf der Investorenseite des Unternehmens zugänglich sein, mit einer Aufnahme, die 90 Tage lang verfügbar bleibt.
- None.
- None.
A live webcast of the fireside chat will be available on the Nuvation Bio website at https://investors.nuvationbio.com/investors/. An archived recording will be available for 90 days following the event.
About Nuvation Bio
Nuvation Bio is a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel product candidates. Nuvation Bio’s portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-1511 (DDC), and NUV-868 (BET). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241126692231/en/
Nuvation Bio Investor Contact:
ir@nuvationbio.com
Nuvation Bio Media Contact:
media@nuvationbio.com
Source: Nuvation Bio Inc.
FAQ
When is Nuvation Bio (NUVB) presenting at the Evercore ISI HealthCONx Conference 2024?
How can I watch Nuvation Bio's (NUVB) presentation at the 2024 HealthCONx Conference?
How long will Nuvation Bio's (NUVB) HealthCONx Conference presentation recording be available?
Who will represent Nuvation Bio (NUVB) at the 2024 Evercore ISI HealthCONx Conference?
